GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Policy Acquisition Expense

Exicure (STU:2H0A) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is Exicure Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Exicure (STU:2H0A) Business Description

Industry
Traded in Other Exchanges
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.